Solid Biosciences (SLDB) Payables (2017 - 2026)
Solid Biosciences (SLDB) reported Payables of $8.9 million for Q1 2026, down 20.7% on a YoY basis from $11.2 million in Q1 2025, and down 28.26% sequentially from $12.4 million in Q4 2025.
Solid Biosciences (SLDB) Payables (2017 - 2026) Analysis & Trends
Solid Biosciences (SLDB) has 10 years of Payables data on file, last reported at $8.9 million in Q1 2026.
- For the quarter ending Q1 2026, Payables fell 20.7% year-over-year to $8.9 million; the trailing twelve-month figure through Mar 2026 stood at $8.9 million (down 20.7% YoY), and the FY2025 full-year result was $12.4 million, up 68.19% from the prior year.
- Payables fell to $8.9 million in Q1 2026, from $12.4 million in the prior quarter.
- In the past five years, Payables ranged from a high of $15.0 million in Q3 2025 to a low of $1.7 million in Q1 2024.
- A 5-year average of $6.3 million and a median of $5.1 million in 2022 frame the typical range for Payables.
- Across the five-year window, Payables plunged 69.08% in 2024 and jumped 549.65% in 2025, its largest moves.
- Tracing SLDB's Payables over 5 years: stood at $3.2 million in 2022, then sank by 37.25% to $2.0 million in 2023, then jumped by 263.53% to $7.4 million in 2024, then jumped by 68.19% to $12.4 million in 2025, then retreated by 28.26% to $8.9 million in 2026.
- Business Quant data shows SLDB's Payables at $8.9 million in Q1 2026, $12.4 million in Q4 2025, and $15.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Solid Biosciences | 529.40 Mn | 529.40 Mn | - | 8.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.91 Mn |
| Dec 31, 2025 | 12.42 Mn |
| Sep 30, 2025 | 14.98 Mn |
| Jun 30, 2025 | 10.40 Mn |
| Mar 31, 2025 | 11.24 Mn |
| Dec 31, 2024 | 7.39 Mn |
| Sep 30, 2024 | 6.86 Mn |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 2.03 Mn |
| Sep 30, 2023 | 1.90 Mn |
| Jun 30, 2023 | 2.97 Mn |
| Mar 31, 2023 | 5.60 Mn |
| Dec 31, 2022 | 3.24 Mn |
| Sep 30, 2022 | 5.15 Mn |
| Jun 30, 2022 | 5.11 Mn |
| Mar 31, 2022 | 4.76 Mn |
| Dec 31, 2021 | 4.46 Mn |
| Sep 30, 2021 | 4.15 Mn |
| Jun 30, 2021 | 3.00 Mn |